About danMalowany

This author has not yet filled in any details.
So far danMalowany has created 66 blog entries.

Nanotherapeutics Announces Name Change

2017-11-29T22:52:24+00:00 October 2nd, 2017|

Nanotherapeutics Announces Name Change to Ology Bioservices, Reflecting the Company’s Ongoing Transformation Into One of the Top Contract Development and Manufacturing Organizations of Vaccines and Biologics ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc. today announced that the Company has changed its name to Ology Bioservices, Inc., effective immediately. The name change is part of a [...]

Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic

2017-11-29T23:18:03+00:00 May 2nd, 2017|

ALACHUA, Fla. & PUNE, India--(BUSINESS WIRE)--Nanotherapeutics Bohumil s.r.o. (a wholly owned subsidiary of Nanotherapeutics, Inc.) and Cyrus Poonawalla Group announced today the final transfer of Nanotherapeutics Bohumil s.r.o.’s vaccine production enterprise located in Bohumil, Czech Republic to Praha Vaccines a.s. Read the full article at Business Wire

Battelle and Nanotherapeutics Form Alliance to Accelerate Medical Countermeasures Development

2017-11-29T22:51:11+00:00 April 6th, 2017|

Battelle and Nanotherapeutics, Inc. announced today that the organizations have entered an alliance to bring together core research, development, test and evaluation (RDT&E) and manufacturing capabilities needed to expedite the development of medical countermeasures urgently required by the Department of Defense (DoD) to protect deployed military forces from Chemical, Biological, Radiological and Nuclear (CBRN) threats.Read [...]

Trethera Corporation and Nanotherapeutics Sign Exclusive Worldwide Agreement for Rights to Triapine® in Hematological Malignancies

2017-11-29T22:51:21+00:00 January 5th, 2017|

Trethera Corporation and Nanotherapeutics Sign Exclusive Worldwide Agreement for Rights to Triapine® in Hematological Malignancies SANTA MONICA, Calif. & ALACHUA, Fla.--(BUSINESS WIRE)--Trethera Corporation and Nanotherapeutics, Inc. today announced the signing of an exclusive worldwide agreement whereby Nanotherapeutics has granted Trethera an exclusive license for the global development, manufacturing and marketing of Triapine® [...]

Nanotherapeutics Appoints Prasad Raje, Ph.D. as President and Chief Executive Officer

2017-11-29T22:58:40+00:00 December 1st, 2016|

Nanotherapeutics Appoints Prasad Raje, Ph.D. as President and Chief Executive Officer ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that Prasad Raje, Ph.D., has been appointed President and Chief Executive Officer, succeeding James M. Matthew, who served as interim President and Chief Executive Officer and will retain [...]

Nanotherapeutics to Present at 28th Annual Piper Jaffray Healthcare Conference

2017-11-29T23:00:48+00:00 November 22nd, 2016|

Nanotherapeutics to Present at 28th Annual Piper Jaffray Healthcare Conference ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that management will give a corporate presentation at the 28th Annual Piper Jaffray Healthcare Conference. Additional information is as follows: Date:                    Wednesday, [...]

Nanotherapeutics Receives NIAID Contract as Part of a Multiple Award Pool for Task Orders Valued at Up to $159.4 Million

2017-11-29T23:03:27+00:00 September 20th, 2016|

ALACHUA, FL, September 20, 2016 (BUSINESSWIRE) - Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the company a contract for advanced biologics manufacturing services as part of a multiple award IDIQ (Indefinite Delivery/Indefinite Quantity) pool. The contract has a maximum ceiling of $159.4 million and a performance period of up to 10 years.

Read the Full Article at BUSINESSWIRE

Former Gates Foundation and Baxter Executive Peter H. Khoury, Ph.D. Joins Nanotherapeutics as Chief Commercial Officer

2017-11-29T23:05:50+00:00 August 3rd, 2016|

Former Gates Foundation and Baxter Executive Peter H. Khoury, Ph.D. Joins Nanotherapeutics as Chief Commercial Officer ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that Peter Khoury, Ph.D. has joined the Company as Senior Vice President and Chief Commercial Officer, effective August 1, 2016. “We are delighted [...]

Nanotherapeutics Closes Sale-Leaseback Financing with Senior Housing Properties Trust for the Company’s New Advanced Development and Manufacturing Facility in Alachua, FL

2017-11-29T23:33:20+00:00 May 6th, 2016|

Nanotherapeutics Closes Sale-Leaseback Financing with Senior Housing Properties Trust for the Company’s New Advanced Development and Manufacturing Facility in Alachua, FL ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, an integrated biopharmaceutical company with a focus on advanced development and manufacturing, today announced the closing of a sale-leaseback transaction with Senior Housing Properties Trust, or SNH, for [...]

Skip to toolbar